MYL3 variants in HCM cohorts


The table below lists the 14 rare (MAF<0.0001 in ExAC) protein-altering MYL3 variants identified in a cohort of 1535 HCM patients. When this rare variant frequency of 0.00912 is compared with a background population rate of 0.00182, there is a statistically significant case excess of 0.00730 (p<0.0001), which suggests that approximately 11 of these variants may be pathogenic.


Variant Type:      All protein-altering variants     -     Truncating variants     -     Non-Truncating variants
Source:      Combined (OMGL + LMM)     -     OMGL     -     LMM



No. Variant (CDS) Variant (Protein) Variant Type Cases (1535)OMGL class ExAC frequency
1. c.383G>A p.G128Dmissense 2VUS0.000000
2. c.463C>G p.H155Dmissense 2Pathogenic0.000000
3. c.521C>T p.A174Vmissense 1VUS0.000008
4. c.454G>A p.E152Kmissense 1VUS0.000000
5. c.128A>C p.K43Tmissense 1VUS0.000000
6. c.461G>A p.R154Hmissense 1VUS0.000024
7. c.539A>G p.N180Smissense 1VUS0.000000
8. c.466G>C p.V156Lmissense 1VUS0.000000
9. c.445A>G p.M149Vmissense 1Pathogenic0.000000
10. c.64G>T p.A22Smissense 1VUS0.000000
11. c.460C>T p.R154Cmissense 1VUS0.000016
12. c.188G>A p.R63Hmissense 1VUS0.000024

References

1. Roddy Walsh, Kate L. Thomson, James S. Ware, Birgit H. Funke, Jessica Woodley, Karen J. McGuire, Francesco Mazzarotto, Edward Blair, Anneke Seller, Jenny C. Taylor, Eric V. Minikel, Exome Aggregation Consortium, Daniel G. MacArthur, Martin Farrall, Stuart A. Cook and Hugh Watkins. Reassessment of Mendelian gene pathogenicity using 7,855 cardiomyopathy cases and 60,706 reference samples. Genet Med. 2016 doi:10.1038/gim.2016.90.

2. Alfares AA, Kelly MA, McDermott G, Funke BH, Lebo MS, Baxter SB, Shen J, McLaughlin HM, Clark EH, Babb LJ, Cox SW, DePalma SR, Ho CY, Seidman JG, Seidman CE, Rehm HL. Results of clinical genetic testing of 2,912 probands with hypertrophic cardiomyopathy: expanded panels offer limited additional sensitivity. Genet Med. 2015 Nov;17(11):880-8.